Search Results 1531-1540 of 17162 for monoclonal antibody

1. An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered via Transendocardial Catheter-based Injections to Subjects with Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) - Mayo Clinic

   ... antibodies. NOTE: Additional lab tests may be performed per local requirements including but not limited to. hepatitis B core antibody; human T lymphotropic ...

2. A Study to Evaluate the Effectiveness and Safety of Ravulizumab in Adult Participants with Neuromyelitis Optica Spectrum Disorder - Mayo Clinic

   Participation eligibility · Patient must be 18 years of age or older, at the time of signing the informed consent. · Anti-aquaporin-4 antibody-positive and a ...

3. Clinical trials - Oncology (Medical)

   This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

4. GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

   Due to rituximab's black box warning for Hepatitis B reactivation, patients with positive hepatitis B core antibody (anti-HBc) should have prophylactic ...

5. Medical Research & Education - Mayo Clinic News Network

   Is the definition of Alzheimer's disease changing? Dana Sparks. November 6, 2018. Mayo researchers correlate specific antibody with relapse of neurological ...

6. Medical Research & Education - Mayo Clinic News Network

   Science Saturday: COVID-19 experimental antibody treatment reaches patients featured image. COVID-19. Science Saturday: COVID-19 experimental antibody ...

7. You need the facts about COVID-19 vaccines - Mayo Clinic News Network

   Your immune system will recognize that the protein doesn't belong there and begin building an immune response and making antibodies. Can a COVID-19 vaccine give ...

8. Safety and Efficacy of ALLO-715 and ALLO-647 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL) - Mayo Clinic

   ... antibody (ALLO-647)-containing regimen in 43 patients with relapsed/refractory multiple myeloma as part A of the ongoing first-in-human phase 1 UNIVERSAL trial.

9. Infectious Diseases Clinical Trials - Mayo Clinic Research

   Our group has explored the use of genomic RNA/phage display libraries derived from primary human malignant melanoma cells as a means of identifying antibody ...

10. A Study to Evaluate UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma - Mayo Clinic

    ... antibodies). No HIV testing ... History of or active hepatitis B (hepatitis B surface antigen reactive) or active hepatitis C (hepatitis C virus antibody).